 |
Benchmark indices ended higher but off day's high on May 10 with Nifty finished above 11,900 level.
At close, the Sensex was up 168.62 points at 39784.52, while Nifty is up 52 points at 11922.70. About 967 shares have advanced, 1619 shares declined, and 172 shares are unchanged.
Britannia Industries, Tech Mahindra, TCS, Infosys and Dr Reddy�s Labs were among major gainers on the Nifty, while losers were BPCL, Yes Bank, Coal India, GAIL and Tata Motors.
Among sectors, except energy and PSU bank all other indices ended higher led by IT, FMCG, pharma, metal and infra.
HEADLINES OF THE DAY
Hero Motocorp received the BS-VI certification for a two-wheeler. The company received the Type Approval Certificate from International Centre for Automotive Technology (ICAT) for the Splendor iSmart motorcycle, after it was successfully tested for compliance to the BS-VI emission norms.
Cipla received EIR from USFDA: This is to inform you that following the inspection by the United States Food and Drug Administration (USFDA) at the Kurkumbh manufacturing facility from March 11, 2019 to March 20, 2019, the company has received the establishment inspection report (EIR), indicating closure of the inspection.
Media and entertainment firm Eros International Media tanked 10 percent on June 10 hitting a record low of Rs 40.95 per share. Short seller Hindenburg Research in a report alleged potential wrongdoing at parent Eros International Plc.
BHEL bags 3 orders: Bharat Heavy Electricals (BHEL) has won three major orders in quick succession, for setting up Solar Photovoltaic (SPV) Power Plants totaling to 135 MW, on engineering, procurement and construction (EPC) basis, in Maharashtra and Gujarat.
PVR opens new multiplex: PVR is opening 10 screens multiplex at Uthandi Mall, Chennai. With this launch, PVR now operates the largest multiplex network with of 781 screens at 166 properties in 67 cities.
Dr Reddy's Laboratories along with its subsidiaries announced positive topline results from its Phase 2b study of PPC-06 (formerly referred to as XP23829) in patients with moderate to severe plaque psoriasis.
The crucial resistance for Nifty spot is now seen at 12040 and above this 12160 Support for the immediate term is now placed at 11780 next support will be 11660.
No comments:
Post a Comment